413 results on '"Jonaitis, Erin M"'
Search Results
2. Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
3. Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results: Associations With Contextual Factors
4. Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals
5. Anticipated reactions to learning Alzheimer’s disease biomarker results
6. Unraveling diurnal and technical variability in cerebral hemodynamics from neurovascular 4D-Flow MRI.
7. Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD‐risk‐enriched cohorts
8. CSF Biomarkers in Longitudinal Alzheimer Disease Cohorts: Pre-Analytic Challenges
9. The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults
10. Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age
11. Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimer's disease
12. Synaptic density is correlated with Aβ plaques and neurofibrillary tau tangles across the clinical and biologic Alzheimer’s disease continuum
13. Longitudinal trajectories of myelin loss in the context of Alzhiemer’s disease biomarkers, glial activation, and APOE4
14. Plasma biomarkers as stand‐alone tests in the diagnosis of Alzheimer’s disease
15. The cerebrospinal fluid A‐T+ Alzheimer disease biomarker profile: prevalence and clinical relevance
16. Using Different Time Operationalizations To Investigate Relationships Among Amyloid PET, White Matter Hyperintensities, And Cognition In A Cognitively Unimpaired Sample
17. Longitudinal changes in blood flow, vessel pulsatility, and trans‐capillary pulse wave delay in small vessel disease and amyloid biomarker positive
18. Cluster analysis of the longitudinal progression of plasma biomarkers and amyloid imaging in the Wisconsin Registry for Alzheimer’s Prevention
19. Examining Complex Relationships among Cerebrovascular, β‐Amyloid, Tau and Cognitive Measures in a Cognitively Unimpaired Late‐Middle Aged Sample
20. Does amyloid moderate practice effects in language measures in a cognitively unimpaired at‐risk sample?
21. A study on the sample representativeness of the Wisconsin Alzheimer’s Disease Research Center Clinical Core participants versus the Wisconsin state population
22. Regional correlation analysis between neuronal metabolism and synaptic density using [18F]FDG and [11C]UCB‐J
23. Peripheral insulin resistance and creatinine levels are associated with plasma phosphorylated tau
24. CSF SNAP‐25 Correlations with Synaptic Density by [11C]‐UCB‐J‐PET Imaging and AD Biomarkers
25. Two novel cerebrospinal fluid markers for vascular injury are associated with CSF markers of AD, neurodegeneration, and gliosis
26. Plasma ALZpath p‐tau217 for the identification of amyloid and tau positivity
27. Assessing the Biological Mechanisms Linking Smoking Behavior and Cognitive Function: A Mediation Analysis of Untargeted Metabolomics
28. Measuring longitudinal cognition: Individual tests versus composites
29. The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
30. Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals
31. Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
32. CSF SNAP‐25 Correlations with Synaptic Density by [11C]‐UCB‐J‐PET Imaging and AD Biomarkers.
33. Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors.
34. Normative Cerebral Hemodynamics in Middle-aged and Older Adults Using 4D Flow MRI: Initial Analysis of Vascular Aging
35. Plasma phosphorylated tau-217 in preclinical Alzheimer’s disease
36. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers
37. Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
38. Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi‐cohort study
39. Associations between Recall of Proper Names in Story Recall and CSF Amyloid and Tau in a Cognitively Unimpaired Sample
40. An examination of baseline plasma Aβ42/40 and intra‐individual cognitive variability (IICV) associations with longitudinal cognitive change in a Black Cohort: Data from the African Americans Fighting Alzheimer’s in Midlife (AA‐FAIM) study
41. Associations between semantic memory for proper names in story recall and CSF amyloid and tau in a cognitively unimpaired sample
42. Assessing the Biological Mechanisms linking Smoking Behavior and Alzheimer’s Disease: Mediation Analysis of Metabolomic Data
43. The role of Cognitive Reserve and depression on executive functions in older adults: a 10‐year longitudinal study
44. Trajectories of cognitive performance in late middle‐aged adults: Bayesian random change point mixed model analysis in WRAP
45. Best combination of CSF biomarkers for predicting cognitive decline and clinical progression: A multi‐cohort study
46. Diabetes is related to cognition but not plasma amyloid‐β 42/40 in an African American cohort
47. Lower synaptic density and higher neurofibrillary tau are associated with worse cognitive performance
48. Apolipoprotein E moderates the association between Non‐ APOE Polygenic Risk Score for Alzheimer’s Disease and Aging on Preclinical Cognitive Function
49. Examining differences across cognitive trajectory profiles in late middle‐aged adults: Results from the Wisconsin Registry for Alzheimer’s Prevention
50. Mid‐to‐Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals from the Wisconsin Registry for Alzheimer’s Prevention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.